Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals: Which Company Reported Better Earnings
Vertex Pharmaceuticals (NASDAQ: VRTX) and Regeneron Pharmaceuticals (NASDAQ: REGN) are two big-cap biotech stocks, and each recently reported second-quarter financial results that were better than analysts were expecting. The two companies, however, target very different disease indications. Vertex Pharmaceuticals is reshaping how doctors treat the life-threatening disease cystic fibrosis, while Regeneron Pharmaceuticals markets drugs used to treat vision loss, high blood cholesterol, and eczema. Is one of these companies executing its business strategy better than the other?
Cystic fibrosis causes a buildup of mucus in the lungs that unfortunately claims the lives of most patients by the time they reach their 40s.
Source: Fool.com
Sanofi S.A. ADR Stock
Sanofi S.A. ADR is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
With a target price of 55 € there is a slightly positive potential of 17.02% for Sanofi S.A. ADR compared to the current price of 47.0 €.